— The Danish drugmaker stock added 5.5% after saying late Tuesday it was halting Ozempic's kidney disease treatment trial after a committee said an analysis showed signs of success.— Shares of dialysis services providers DaVita and Fresenius Medical Care sank 18.4% and 19.6%, respectively, on Novo Nordisk's news. Baxter International, which makes products for chronic dialysis therapies, slid 9%.shale rival Pioneer Natural Resources for $59.
Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weekly— Shares slipped 2% after CEO Bruce Broussard said he will step down from his position in the latter half of 2024. The company named Jim Rechtin of ENvision Healthcare as his successor.— The biopharma stock added 3.5% following an upgrade from Leerink to outperform. Analyst David Risinger cited an expanding earnings multiple and pipeline newsflow as catalysts.— Shares gained 6.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: NBCNewYork - 🏆 270. / 63 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »